Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Accumulated Expenses (2016 - 2025)

Healthstream (HSTM) has disclosed Accumulated Expenses for 16 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 10.11% to $11.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.2 million, a 10.11% increase, with the full-year FY2025 number at $11.2 million, up 10.11% from a year prior.
  • Accumulated Expenses was $11.2 million for Q4 2025 at Healthstream, up from $10.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $25.0 million in Q4 2022 to a low of $4.2 million in Q2 2024.
  • A 5-year average of $9.5 million and a median of $6.7 million in 2022 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 274.04% in 2023; the steepest drop was 81.79% in 2023.
  • Healthstream's Accumulated Expenses stood at $16.4 million in 2021, then surged by 52.79% to $25.0 million in 2022, then tumbled by 81.79% to $4.6 million in 2023, then skyrocketed by 122.59% to $10.1 million in 2024, then rose by 10.11% to $11.2 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Accumulated Expenses are $11.2 million (Q4 2025), $10.6 million (Q3 2025), and $4.8 million (Q2 2025).